Formoterol

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3135 publications

Carbon-Based Electrochemical Sensors and Voltammetry for the Detection of Biologically Active Molecules: Fundamentals, Theoretical Aspects, and Emerging Perspectives.

Carbon-Based Electrochemical Sensors and Voltammetry for the Detection of Biologically Active Molecules: Fundamentals, Theoretical Aspects, and Emerging Perspectives.

Journal: Langmuir : the ACS journal of surfaces and colloids

Published: December 29, 2025

Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease.

Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease.

Journal: Journal of comparative effectiveness research

Published: December 15, 2025

Evaluating the Real-world Effectiveness and Safety of Formoterol Fumarate and Fluticasone Propionate Combination in Asthma: A Prospective, Multicenter Study.

Evaluating the Real-world Effectiveness and Safety of Formoterol Fumarate and Fluticasone Propionate Combination in Asthma: A Prospective, Multicenter Study.

Journal: The Journal of the Association of Physicians of India

Published: November 24, 2025

Improved lung function with beclomethasone/formoterol versus beclomethasone alone in asthma: the FORCE2 study.

Improved lung function with beclomethasone/formoterol versus beclomethasone alone in asthma: the FORCE2 study.

Journal: The Journal of asthma : official journal of the Association for the Care of Asthma

Published: November 13, 2025

Correction to: Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/ Formoterol Fumarate in General Practice in England.

Correction to: Real-World Comparative Effectiveness Study in Patients with Asthma Initiating Fluticasone Furoate/Vilanterol or Beclometasone Dipropionate/ Formoterol Fumarate in General Practice in England.

Journal: Advances in therapy

Published: November 01, 2025

IS AS NEEDED THERAPY WITH AN INHALED BUDESONIDE/FORMOTEROL COMBINATION ONLY WHEN SYMPTOMATIC AS AN OPTION IN THE MANAGEMENT OF PATIENTS WITH MILD ASTHMA?

IS AS NEEDED THERAPY WITH AN INHALED BUDESONIDE/FORMOTEROL COMBINATION ONLY WHEN SYMPTOMATIC AS AN OPTION IN THE MANAGEMENT OF PATIENTS WITH MILD ASTHMA?

Journal: Arerugi = [Allergy]

Published: October 13, 2025

Maintenance and Reliever Therapy in Pediatric Asthma: A Concise Review of Recent Evidence-Part I.

Maintenance and Reliever Therapy in Pediatric Asthma: A Concise Review of Recent Evidence-Part I.

Journal: Pediatric annals

Published: October 08, 2025

Budesonide/formoterol for pediatric asthma: bridging the gap between evidence and practice in Maintenance and Reliever Therapy.

Budesonide/formoterol for pediatric asthma: bridging the gap between evidence and practice in Maintenance and Reliever Therapy.

Journal: Frontiers in medicine

Published: September 24, 2025

A current assessment of family physicians' knowledge and attitudes toward asthma management in primary care in Turkey according to the GINA strategy report.

A current assessment of family physicians' knowledge and attitudes toward asthma management in primary care in Turkey according to the GINA strategy report.

Journal: NPJ primary care respiratory medicine

Published: September 22, 2025

Comments on: "Formoterol, a clinically approved drug, inhibits ferroptosis by suppressing lipid peroxidation and attenuates APAP-induced acute liver injury".

Comments on: "Formoterol, a clinically approved drug, inhibits ferroptosis by suppressing lipid peroxidation and attenuates APAP-induced acute liver injury".

Journal: Chemico-biological interactions

Published: September 17, 2025

Effectiveness and Safety of Glycopyrronium-Formoterol-Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study.

Effectiveness and Safety of Glycopyrronium-Formoterol-Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study.

Journal: Advances in respiratory medicine

Published: September 16, 2025

Optimizing the Use of Inhaled Corticosteroid/Long-Acting β2-Agonist Combinations in Patients with Moderate-to-Severe Asthma.

Optimizing the Use of Inhaled Corticosteroid/Long-Acting β2-Agonist Combinations in Patients with Moderate-to-Severe Asthma.

Journal: Advances in therapy

Published: September 04, 2025

Showing 1-12 of 3,135

Last Updated: 02/24/2026